At Upsilon Global, we are aware of the challenges faced by smaller CROs when competing with larger competitors at bid-defence stage, so we developed our business development model to enable our CRO partners to obtain previously out-of-reach studies. Based on the specifics of your sponsor’s request for proposal (RFP), we work with you to identify the best strategy for increasing your chances of success.
Whether by indication or cost-effectiveness, we identify a therapeutically-aligned and geographically-focused multi-country study team for use throughout the bid process, in which each expert has the specific therapeutic experience, expertise in the local regulatory laws, existing PI/KOL contacts and, most importantly, speaks the native language.
The way our bid-defence model works guarantees no cost implication to you, the CRO, whilst allowing you to increase your proposals pipeline and chances of success. We act as a virtual extension of your company and allow you to conduct trials internationally without the fixed overheads, cost layers or multiple communication lines that come with using partner CROs.